Ethanol consumption for subjects in the levetiracetam (LEV), placebo (PLC), topiramate (TOP), and zonisamide (ZON) groups. Mean (SE) weekly values are presented for drinks per day (top) and percent days heavy drinking (bottom) obtained during the prescreening (Week 0), titration (weeks 1-7), and maintenance phases of the study (weeks 8-12).